Driving compliance in fully remote Alzheimer’s trials is complex, ICON Concierge Services makes it possible. In a pre-clinical study with 600+ participants and over 50 ePROs per patient, Concierge direct-to-patient serv...
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Preparing for 2026
Vicki Anastasi contributes to this article which looks atvalue-based healthcare, enabled by wearable and electronic health record (EHR) technologies.
-
One Answer to Your Postmarket Challenge: Planning
Interview with Vicki Anastasi onpostmarket surveillance and the challenges trial designs are facing.
-
The Clinical Trial of the Future
Steve Cutler talks to Pharma Times regarding industry trends inclinical trials and patient engagement.
-
Match This
Due to considerable market growth, biosimilar clinical trials are rising in popularity. One key example relates to rituximab, and the development of its biosimilars is currently leading the way in clinical research.
-
Remote Monitoring of Patients in Clinical Trials
Recent initiatives to redesign theclinical trial processhave in part focused on the creation of trials that are more patient focused.
-
Adaptive Designs for Clinical Trials
Read more aboutadaptive design for clinical trialsand how it can improve speed to market.
-
Adaptive designs patient value
Vicki Anastasi contributes to this article that looks at adaptive designs patient value and commercial benefits.
-
The Patient Data Gold Rush
Tom O'Leary's presentation to the Financial Times Digital Health Summit Europe is covered in this article regarding the use of technology tomine the clinical data patient.
-
Bring Your Own Device for Trial Outcome Assessment
A research survey to identify and assess the perceived barriers and challenges with the use ofBYOD for eCOA in clinical trials.
-
Countermeasures to Oncology Trial Failure: 5 Smarter Approaches to Trial Design and Analysis
5 Smarter Approaches to Trial Design and Analysis
Alan Phillips, Vice President, Biostatistics and Jia Ma, Senior Program Manager, Biostatistics, of ICON Clinical Research contribute to this article onCountermeasures to Oncology TrialFailures.
